Skip to Content
DiseasesDiseases
  • Article
  • Open Access

18 November 2026

16 Pages

Psychiatric and Neuropsychiatric Phenotypes in Alcohol-Related Liver Disease: Clinical and Biochemical Associations

,
,
,
and
1
Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, 35 Al. I. Cuza Street, 800008 Galati, Romania
2
“Sf. Apostol Andrei” Emergency County Clinical Hospital Galati, 177 Brailei Street, 800578 Galati, Romania
3
“Elisabeta Doamna” Clinical Hospital of Psychiatry Galati, 290 Traian Street, 800179 Galati, Romania
*
Authors to whom correspondence should be addressed.
This article belongs to the Section Neuro-psychiatric Disorders

Abstract

Background: Alcohol-related liver disease (ALD) is frequently accompanied by psychiatric and neuropsychiatric manifestations that contribute to disease complexity. This hospital-based observational study aimed to characterize psychiatric and neuropsychiatric comorbidity patterns in a single-center series of 50 patients with ALD and to explore their associations with demographic characteristics and biochemical profiles, including serum immunoglobulin A (IgA) and immunoglobulin G (IgG). Methods: In this observational study, 50 consecutively hospitalized patients with ALD were evaluated. Neuropsychiatric manifestations—namely hepatic encephalopathy (HE, assessed clinically and graded using West Haven criteria), anxiety-depressive manifestations, delirium tremens, alcohol-related psychosis, and insomnia—were recorded based on clinical evaluation without standardized psychometric rating scales. Demographic characteristics and biochemical parameters (IgA, IgG, liver enzymes, bilirubin, albumin, INR, hemoglobin, MCV, and platelets) were compared between groups using non-parametric tests. Multivariable logistic regression was used to identify factors associated with HE. Results: HE was present in 60% of patients, anxiety-depressive manifestations in 54.0%, insomnia in 50.0%, alcoholic psychosis in 22%, and delirium tremens in 16.0%. Patients with HE exhibited significantly higher IgA (7.09 ± 2.33 vs. 4.94 ± 2.39 g/L, p = 0.003) and IgG concentrations (16.83 ± 3.68 vs. 13.72 ± 4.55 g/L, p = 0.029), alongside lower hemoglobin levels (p = 0.025). In multivariable analysis, age 51–70 years (OR = 11.882, 95% CI: 2.268–62.244, p = 0.003) and higher IgG concentrations (OR = 1.288 per g/L, 95% CI: 1.035–1.603, p = 0.023) remained independently associated with HE. Conclusions: Psychiatric and neuropsychiatric comorbidities are frequent in hospitalized patients with ALD. Given the observational design, lack of standardized psychometric scales, and small sample size, these exploratory findings—particularly the immunological associations—require validation in larger prospective cohorts.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.